Replies to post #106068 on Anavex Life Sciences Corp (AVXL)

[TomP1]

Too much negative history to overcome regarding Alzheimer.

[riaguy]

When you have a CEO who doesn't report progress in an ongoing trial, it's difficult to generate any enthusiasm for the stock.
I find it exceedingly strange that many on this board found the allowance of patent notice on the US patent site but the company has said nothing in regards to the patent application.
Given the excellent scientific comments by Dado and many others, the share price has held in the current area for a couple of years but eventually Wall Street loses patience with a non-communicative management structure.
Missling needs to analyze his attitude towards his shareholders and disseminate some information in the near future.

[falconer66a]

No, takes some developed biological knowledge to be able to understand the unique, revolutionary biochemical mechanisms of Anavex 2-73, all of which point to remarkable future successes.

The general market is, by and large, clueless as to Anavex biology. Therefore, no big share price increases until information appears that the general public can understand, such as approval or conduct of new clinical trials. Presently, there is nothing the non-scientific crowd can connect with to AVXL.

In time, the entire world will learn of the Anavex revolution. (But most of us here, will have been in early, persisted, and will reap great rewards.)